7 research outputs found

    Characterization of Anopheles gambiae s.l. and insecticide resistance profile relative to physicochemical properties of breeding habitats within Accra Metropolis, Ghana

    Get PDF
    Malaria is endemic in Ghana as in most countries of sub-Saharan Africa. This study was conducted to characterize Anopheles gambiae s.l. and determine pyrethroid resistance profiles relative to physicochemical properties of breeding habitats in Accra, Ghana. Eight aquatic habitats containing Anopheles larvae were identified and from each habitat, larvae and water were sampled. Adult An. gambiae reared from larvae were morphologically identified and tested for permethrin (0.75%) and deltamethrin (0.05%) resistance using WHO bioassay method. An. gambiae s.s. found were identified to their molecular levels and kdr mutation detected using PCR-based methods. Twenty-nine physicochemical parameters of each water sample were measured and their levels connected with pyrethroid resistance and proportions of An. gambiae s.s. molecular forms in habitats. A total of 2,257 mosquitoes were morphologically identified as An. gambiae s.l. and all 224 processed for PCR were identified as An. gambiae s.s., of which 56.46% and 43.54% were M and S-forms, respectively. Both forms occurred in sympatry in all larval habitats and no S/M hybrids were detected. However, M-form larvae were in high proportion in polluted habitats than the S-form. An. gambiae s.s. was highly resistant to both deltamethrin and permethrin with mortality rates of 42.98-70.0% and 6.5-20.0% respectively. The frequency of kdr mutation was 60.5 % (n=195). This mutation occurred in both S and M-forms, but was mainly associated with the S-form (X2=10.92, df =1, P=0.001). Carbonate and pH were both selected in discriminant function analysis as best predictors of high proportion of M-form in the habitats. The adaptation of An. gambiae s.s. in polluted aquatic habitats coupled with occurrence of insecticide resistance is quite alarming particularly for urban malaria control and needs further exploration in a wider context

    Characterization of Anopheles gambiae s.l. and insecticide resistance profile relative to physicochemical properties of breeding habitats within Accra Metropolis, Ghana

    No full text
    Malaria is endemic in Ghana as in most countries of sub-Saharan Africa. This study was conducted to characterize Anopheles gambiae s.l. and determine pyrethroid resistance profiles relative to physicochemical properties of breeding habitats in Accra, Ghana. Eight aquatic habitats containing Anopheles larvae were identified and from each habitat, larvae and water were sampled. Adult An. gambiae reared from larvae were morphologically identified and tested for permethrin (0.75%) and deltamethrin (0.05%) resistance using WHO bioassay method. An. gambiae s.s. found were identified to their molecular levels and kdr mutation detected using PCR-based methods. Twenty-nine physicochemical parameters of each water sample were measured and their levels connected with pyrethroid resistance and proportions of An. gambiae s.s. molecular forms in habitats. A total of 2,257 mosquitoes were morphologically identified as An. gambiae s.l. and all 224 processed for PCR were identified as An. gambiae s.s., of which 56.46% and 43.54% were M and S-forms, respectively. Both forms occurred in sympatry in all larval habitats and no S/M hybrids were detected. However, M-form larvae were in high proportion in polluted habitats than the S-form. An. gambiae s.s. was highly resistant to both deltamethrin and permethrin with mortality rates of 42.98-70.0% and 6.5-20.0% respectively. The frequency of kdr mutation was 60.5 % (n=195). This mutation occurred in both S and M-forms, but was mainly associated with the S-form (X2=10.92, df =1, P=0.001). Carbonate and pH were both selected in discriminant function analysis as best predictors of high proportion of M-form in the habitats. The adaptation of An. gambiae s.s. in polluted aquatic habitats coupled with occurrence of insecticide resistance is quite alarming particularly for urban malaria control and needs further exploration in a wider context

    Improved spatial ecological sampling using open data and standardization: an example from malaria mosquito surveillance

    No full text
    Vector-borne disease control relies on efficient vector surveillance, mostly carried out using traps whose number and locations are often determined by expert opinion rather than a rigorous quantitative sampling design. In this work we propose a framework for ecological sampling design which in its preliminary stages can take into account environmental conditions obtained from open data (i.e. remote sensing and meteorological stations) not necessarily designed for ecological analysis. These environmental data are used to delimit the area into ecologically homogeneous strata. By employing Bayesian statistics within a model-based sampling design, the traps are deployed among the strata using a mixture of random and grid locations which allows balancing predictions and model-fitting accuracies. Sample sizes and the effect of ecological strata on sample sizes are estimated from previous mosquito sampling campaigns open data. Notably, we found that a configuration of 30 locations with four households each (120 samples) will have a similar accuracy in the predictions of mosquito abundance as 200 random samples. In addition, we show that random sampling independently from ecological strata, produces biased estimates of the mosquito abundance. Finally, we propose standardizing reporting of sampling designs to allow transparency and repetition/re-use in subsequent sampling campaigns

    Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021

    No full text
    Abstract Background Therapeutic efficacy studies (TESs) and detection of molecular markers of drug resistance are recommended by the World Health Organization (WHO) to monitor the efficacy of artemisinin-based combination therapy (ACT). This study assessed the trends of molecular markers of artemisinin resistance and/or reduced susceptibility to lumefantrine using samples collected in TES conducted in Mainland Tanzania from 2016 to 2021. Methods A total of 2,015 samples were collected during TES of artemether-lumefantrine at eight sentinel sites (in Kigoma, Mbeya, Morogoro, Mtwara, Mwanza, Pwani, Tabora, and Tanga regions) between 2016 and 2021. Photo-induced electron transfer polymerase chain reaction (PET-PCR) was used to confirm presence of malaria parasites before capillary sequencing, which targeted two genes: Plasmodium falciparum kelch 13 propeller domain (k13) and P. falciparum multidrug resistance 1 (pfmdr1). Results Sequencing success was ≥ 87.8%, and 1,724/1,769 (97.5%) k13 wild-type samples were detected. Thirty-seven (2.1%) samples had synonymous mutations and only eight (0.4%) had non-synonymous mutations in the k13 gene; seven of these were not validated by the WHO as molecular markers of resistance. One sample from Morogoro in 2020 had a k13 R622I mutation, which is a validated marker of artemisinin partial resistance. For pfmdr1, all except two samples carried N86 (wild-type), while mutations at Y184F increased from 33.9% in 2016 to about 60.5% in 2021, and only four samples (0.2%) had D1246Y mutations. pfmdr1 haplotypes were reported in 1,711 samples, with 985 (57.6%) NYD, 720 (42.1%) NFD, and six (0.4%) carrying minor haplotypes (three with NYY, 0.2%; YFD in two, 0.1%; and NFY in one sample, 0.1%). Between 2016 and 2021, NYD decreased from 66.1% to 45.2%, while NFD increased from 38.5% to 54.7%. Conclusion This is the first report of the R622I (k13 validated mutation) in Tanzania. N86 and D1246 were nearly fixed, while increases in Y184F mutations and NFD haplotype were observed between 2016 and 2021. Despite the reports of artemisinin partial resistance in Rwanda and Uganda, this study did not report any other validated mutations in these study sites in Tanzania apart from R622I suggesting that intensified surveillance is urgently needed to monitor trends of drug resistance markers and their impact on the performance of ACT
    corecore